CIRMAP - Centre d'Innovation et de Recherche en Matériaux Polymères
Disciplines :
Chemistry
Author, co-author :
Frère, Antoine
Baroni, Alexandra ; Université de Mons > Faculté de Médecine et de Pharmacie > Analyse pharmaceutique ; Université de Mons > Faculté des Sciences > Matériaux Polymères et Composites
Hendrick, Elodie
Delvigne, Anne-Sophie
Orange, François
Peulen, O.
R Dakwar, George
DIRICQ, Jérôme
Dubois, Philippe ; Université de Mons > Faculté des Sciences > Matériaux Polymères et Composites
Evrard, Brigitte
Remaut, Katrien
Braeckmans, Kevin
C. De Smedt, Stefaan
Laloy, Julie
Dogné, Jean-Michel
Feller, Georges
Mespouille, Laetitia ; Université de Mons > Faculté des Sciences > Matériaux Polymères et Composites
Glozak, M. A.; Seto, E. Histone Deacetylases and Cancer. Oncogene 2007, 26, 5420-5432.
Zhang, L.; Han, Y.; Jiang, Q.; Wang, C.; Chen, X.; Li, X.; Xu, F.; Jiang, Y.; Wang, Q.; Xu, W. Trend of Histone Deacetylase Inhibitors in Cancer Therapy: Isoform Selectivity or Multitargeted Strategy. Med. Res. Rev. 2015, 35, 63-84.
Mottamal, M.; Zheng, S.; Huang, T. L.; Wang, G. Histone Deacetylase Inhibitors in Clinical Studies as Templates for New Anticancer Agents. Molecules 2015, 20, 3898-3941.
Zhang, J.; Zhong, Q. Histone Deacetylase Inhibitors and Cell Death. Cell. Mol. Life Sci. 2014, 71, 3885-3901.
Chun, P. Histone Deacetylase Inhibitors in Hematological Malignancies and Solid Tumors. Arch. Pharmacal Res. 2015, 38, 933-949.
Finnin, M. S.; Donigian, J. R.; Cohen, A.; Richon, V. M.; Rifkind, R. A.; Marks, P. A.; Breslow, R.; Pavletich, N. P. Structures of a Histone Deacetylase Homologue Bound to the TSA and SAHA Inhibitors. Nature 1999, 401, 188-193.
Peixoto, P.; Castronovo, V.; Matheus, N.; Polese, C.; Peulen, O.; Gonzalez, A.; Boxus, M.; Verdin, E.; Thiry, M.; Dequiedt, F.; Mottet, D. HDAC5 Is Required for Maintenance of Pericentric Heterochromatin, and Controls Cell-Cycle Progression and Survival of Human Cancer Cells. Cell Death Differ. 2012, 19, 1239-1252.
Fan, J.; Lou, B.; Chen, W.; Zhang, J.; Lin, S.; Lv, F. F.; Chen, Y. Down-Regulation of HDAC5 Inhibits Growth of Human Hepatocellular Carcinoma by Induction of Apoptosis and Cell Cycle Arrest. Tumor Biol. 2014, 35, 11523-11532.
Liu, J.; Gu, J.; Feng, Z.; Yang, Y.; Zhu, N.; Lu, W.; Qi, F. Both HDAC5 and HDAC6 Are Required for the Proliferation and Metastasis of Melanoma Cells. J. Transl. Med. 2016, 14, 7-19.
Fire, A.; Xu, S.; Montgomery, M. K.; Kostas, S. A.; Driver, S. E.; Mello, C. C. Potent and Specific Genetic Interference by Double-Stranded RNA in. Nature 1998, 391, 806-811.
Elbashir, S. M.; Harborth, J.; Lendeckel, W.; Yalcin, A.; Weber, K.; Tuschl, T. Duplexes of 21-Nucleotide RNAs Mediate RNA Interference in Cultured Mammalian Cells. Nature 2001, 411, 494-498.
Oh, Y. K.; Park, T. G. siRNA Delivery Systems for Cancer Treatment. Adv. Drug Delivery Rev. 2009, 61, 850-862.
Corbet, C.; Ragelle, H.; Pourcelle, V.; Vanvarenberg, K.; Marchand-Brynaert, J.; Préat, V.; Feron, O. Delivery of siRNA Targeting Tumor Metabolism Using Non-Covalent Pegylated Chitosan Nanoparticles: Identification of an Optimal Combination of Ligand Structure, Linker and Grafting Method. J. Controlled Release 2016, 223, 53-63.
Daka, A.; Peer, D. RNAi-Based Nanomedicines for Targeted Personalized Therapy. Adv. Drug Delivery Rev. 2012, 64, 1508-1521.
Ambardekar, V. V.; Han, H. Y.; Varney, M. L.; Vinogradov, S. V.; Singh, R. K.; Vetro, J. A. The Modification of siRNA with 3′ Cholesterol to Increase Nuclease Protection and Suppression of Native mRNA by Select siRNA Polyplexes. Biomaterials 2011, 32, 1404-1411.
Bertrand, N.; Leroux, J. C. The Journey of a Drug-Carrier in the Body: An Anatomo-Physiological Perspective. J. Controlled Release 2012, 161, 152-163.
Varkouhi, A. K.; Scholte, M.; Storm, G.; Haisma, H. J. Endosomal Escape Pathways for Delivery of Biologicals. J. Controlled Release 2011, 151, 220-228.
Fang, J.; Nakamura, H.; Maeda, H. The Epr Effect: Unique Features of Tumor Blood Vessels for Drug Delivery, Factors Involved, and Limitations and Augmentation of the Effect. Adv. Drug Delivery Rev. 2011, 63, 136-151.
Xiang, S.; Tong, H.; Shi, Q.; Fernandes, J. C.; Jin, T.; Dai, K.; Zhang, X. Uptake Mechanisms of Non-Viral Gene Delivery. J. Controlled Release 2012, 158, 371-378.
Barua, S.; Mitragotri, S. Challenges Associated with Penetration of Nanoparticles across Cell and Tissue Barriers: A Review of Current Status and Future Prospects. Nano Today 2014, 9, 223-243.
Tempelaar, S.; Mespouille, L.; Coulembier, O.; Dubois, P.; Dove, A. P. Synthesis and Post-Polymerisation Modifications of Aliphatic Poly(Carbonate)s Prepared by Ring-Opening Polymerisation. Chem. Soc. Rev. 2013, 42, 1312-1336.
Chen, W.; Meng, F.; Cheng, R.; Deng, C.; Feijen, J.; Zhong, Z. Advanced Drug and Gene Delivery Systems Based on Functional Biodegradable Polycarbonates and Copolymers. J. Controlled Release 2014, 190, 398-414.
Ong, Z. Y.; Fukushima, K.; Coady, D. J.; Yang, Y. Y.; Ee, P. L.; Hedrick, J. L. Rational Design of Biodegradable Cationic Polycarbonates for Gene Delivery. J. Controlled Release 2011, 152, 120-126.
de la Rosa, V. R.; Tempelaar, S.; Dubois, P.; Hoogenboom, R.; Mespouille, L. Poly(2-Ethyl-2-Oxazoline)-Block-Polycarbonate Block Copolymers: From Improved End-Group Control in Poly(2-Oxazoline)s to Chain Extension with Aliphatic Polycarbonate through a Fully Metal-Free Ring-Opening Polymerisation Process. Polym. Chem. 2016, 7, 1559-1568.
Frère, A.; Kawalec, M.; Tempelaar, S.; Peixoto, P.; Hendrick, E.; Peulen, O.; Evrard, B.; Dubois, P.; Mespouille, L.; Mottet, D.; Piel, G. Impact of the Structure of Biocompatible Aliphatic Polycarbonates on siRNA Transfection Ability. Biomacromolecules 2015, 16, 769-779.
Geihe, E. I.; Cooley, C. B.; Simon, J. R.; Kiesewetter, M. K.; Edward, J. A.; Hickerson, R. P.; Kaspar, R. L.; Hedrick, J. L.; Waymouth, R. M.; Wender, P. A. Designed Guanidinium-Rich Amphipathic Oligocarbonate Molecular Transporters Complex, Deliver and Release siRNA in Cells. Proc. Natl. Acad. Sci. U. S. A. 2012, 109, 13171-13176.
Bartolini, C.; Mespouille, L.; Verbruggen, I.; Willem, R.; Dubois, P. Guanidine-Based Polycarbonate Hydrogels: From Metal-Free Ring-Opening Polymerization to Reversible Self-Assembling Properties. Soft Matter 2011, 7, 9628-9637.
Reschner, A.; Shim, Y. H.; Dubois, P.; Delvenne, P.; Evrard, B.; Marcelis, L.; Moucheron, C.; Kirsch-De Mesmaeker, A.; Defrancq, E.; Raes, M.; Piette, J.; Collard, L.; Piel, G. Evaluation of a New Biocompatible Poly(N-(Morpholino Ethyl Methacrylate)-Based Copolymer for the Delivery of Ruthenium Oligonucleotides, Targeting HPV16 E6 Oncogene. J. Biomed. Nanotechnol. 2013, 9, 1432-1440.
Zhao, Z. X.; Gao, S. Y.; Wang, J. C.; Chen, C. J.; Zhao, E. Y.; Hou, W. J.; Feng, Q.; Gao, L. Y.; Liu, X. Y.; Zhang, L. R.; Zhang, Q. Self-Assembly Nanomicelles Based on Cationic mPEG-PLA-b-Polyarginine(R15) Triblock Copolymer for siRNA Delivery. Biomaterials 2012, 33, 6793-6807.
Omedes Pujol, M.; Coleman, D. J. L.; Allen, C. D.; Heidenreich, O.; Fulton, D. A. Determination of Key Structure-Activity Relationships in siRNA Delivery with a Mixed Micelle System. J. Controlled Release 2013, 172, 939-945.
Li, J.; Chen, Q.; Zha, Z.; Li, H.; Toh, K.; Dirisala, A.; Matsumoto, Y.; Osada, K.; Kataoka, K.; Ge, Z. Ternary Polyplex Micelles with PEG Shells and Intermediate Barrier to Complexed DNA Cores for Efficient Systemic Gene Delivery. J. Controlled Release 2015, 209, 77-87.
Fukushima, K. Poly(Trimethylene Carbonate)-Based Polymers Engineered for Biodegradable Functional Biomaterials. Biomater. Sci. 2016, 4, 9-24.
Mespouille, L.; Coulembier, O.; Kawalec, M.; Dove, A. P.; Dubois, P. Implementation of Metal-Free Ring-Opening Polymerization in the Preparation of Aliphatic Polycarbonate Materials. Prog. Polym. Sci. 2014, 39, 1144-1164.
Nachtergael, A.; Coulembier, O.; Dubois, P.; Helvenstein, M.; Duez, P.; Blankert, B.; Mespouille, L. Organocatalysis Paradigm Revisited: Are Metal-Free Catalysts Really Harmless? Biomacromolecules 2015, 16, 507-514.
Mespouille, L.; Nederberg, F.; Hedrick, J. L.; Dubois, P. Broadening the Scope of Functional Groups Accessible in Aliphatic Polycarbonates by the Introduction of Raft Initiating Sites. Macromolecules 2009, 42, 6319-6321.
Palchetti, S.; Colapicchioni, V.; Digiacomo, L.; Caracciolo, G.; Pozzi, D.; Capriotti, A. L.; La Barbera, G.; Lagana, A. The Protein Corona of Circulating Pegylated Liposomes. Biochim. Biophys. Acta, Biomembr. 2016, 1858, 189-196.
Dakwar, G. R.; Zagato, E.; Delanghe, J.; Hobel, S.; Aigner, A.; Denys, H.; Braeckmans, K.; Ceelen, W.; De Smedt, S. C.; Remaut, K. Colloidal Stability of Nano-Sized Particles in the Peritoneal Fluid: Towards Optimizing Drug Delivery Systems for Intraperitoneal Therapy. Acta Biomater. 2014, 10, 2965-2975.
Gaumet, M.; Vargas, A.; Gurny, R.; Delie, F. Nanoparticles for Drug Delivery: The Need for Precision in Reporting Particle Size Parameters. Eur. J. Pharm. Biopharm. 2008, 69, 1-9.
Maeda, H.; Wu, J.; Sawa, T.; Matsumura, Y.; Hori, K. Tumor Vascular Permeability and the EPR Effect in Macromolecular Therapeutics: A Review. J. Controlled Release 2000, 65, 271-284.
de Wolf, H. K.; Luten, J.; Snel, C. J.; Oussoren, C.; Hennink, W. E.; Storm, G. In Vivo Tumor Transfection Mediated by Polyplexes Based on Biodegradable Poly(DMAEA)-Phosphazene. J. Controlled Release 2005, 109, 275-287.
Laloy, J.; Minet, V.; Alpan, L.; Mullier, F.; Beken, S.; Toussaint, O.; Lucas, S.; Dogné, J.-M. Impact of Silver Nanoparticles on Haemolysis, Platelet Function and Coagulation. Nanobiomedicine 2014, 1.110.5772/59346
Leclercq, L.; Modena, E.; Vert, M. Adsorption of Proteins at Physiological Concentrations on Pegylated Surfaces and the Compatibilizing Role of Adsorbed Albumin with Respect to Other Proteins According to Optical Waveguide Lightmode Spectroscopy (OWLS). J. Biomater. Sci., Polym. Ed. 2013, 24, 1499-1518.
Kolate, A.; Baradia, D.; Patil, S.; Vhora, I.; Kore, G.; Misra, A. PEG-A Versatile Conjugating Ligand for Drugs and Drug Delivery Systems. J. Controlled Release 2014, 192, 67-81.
Beck-Broichsitter, M.; Nicolas, J.; Couvreur, P. Design Attributes of Long-Circulating Polymeric Drug Delivery Vehicles. Eur. J. Pharm. Biopharm. 2015, 97, 304-317.
Owens, D. E., 3rd; Peppas, N. A. Opsonization, Biodistribution, and Pharmacokinetics of Polymeric Nanoparticles. Int. J. Pharm. 2006, 307, 93-102.
Cedervall, T.; Lynch, I.; Lindman, S.; Berggard, T.; Thulin, E.; Nilsson, H.; Dawson, K. A.; Linse, S. Understanding the Nanoparticle-Protein Corona Using Methods to Quantify Exchange Rates and Affinities of Proteins for Nanoparticles. Proc. Natl. Acad. Sci. U. S. A. 2007, 104, 2050-2055.
Buyens, K.; Lucas, B.; Raemdonck, K.; Braeckmans, K.; Vercammen, J.; Hendrix, J.; Engelborghs, Y.; De Smedt, S. C.; Sanders, N. N. A Fast and Sensitive Method for Measuring the Integrity of siRNA-Carrier Complexes in Full Human Serum. J. Controlled Release 2008, 126, 67-76.
Braeckmans, K.; Buyens, K.; Bouquet, W.; Vervaet, C.; Joye, P.; De Vos, F.; Plawinski, L.; Doeuvre, L.; Angles-Cano, E.; Sanders, N. N.; Demeester, J.; De Smedt, S. C. Sizing Nanomatter in Biological Fluids by Fluorescence Single Particle Tracking. Nano Lett. 2010, 10, 4435-4442.
Peulen, O.; Gonzalez, A.; Peixoto, P.; Turtoi, A.; Mottet, D.; Delvenne, P.; Castronovo, V. The Anti-Tumor Effect of HDAC Inhibition in a Human Pancreas Cancer Model Is Significantly Improved by the Simultaneous Inhibition of Cyclooxygenase 2. PLoS One 2013, 8, e75102.
Turnbull, W. B.; Daranas, A. H. On the Value of C: Can Low Affinity Systems Be Studied by Isothermal Titration Calorimetry? J. Am. Chem. Soc. 2003, 125, 14859-14866.
Velazquez Campoy, A.; Freire, E. ITC in the Post-Genomic Era? Priceless. Biophys. Chem. 2005, 115, 115-124.
Machinskaya, A. E.; Leclercq, L.; Boustta, M.; Vert, M.; Vasilevskaya, V. V. Salt Effects on Macrophase Separations in Non-Stoichiometric Mixtures of Oppositely Charged Macromolecules: Theory and Experiment. J. Polym. Sci., Part B: Polym. Phys. 2016, 54, 1717-1730.
Blanco, E.; Shen, H.; Ferrari, M. Principles of Nanoparticle Design for Overcoming Biological Barriers to Drug Delivery. Nat. Biotechnol. 2015, 33, 941-951.
Favretto, M. E.; Wallbrecher, R.; Schmidt, S.; van de Putte, R.; Brock, R. Glycosaminoglycans in the Cellular Uptake of Drug Delivery Vectors-Bystanders or Active Players? J. Controlled Release 2014, 180, 81-90.
Tantra, R.; Schulze, P.; Quincey, P. Effect of Nanoparticle Concentration on Zeta-Potential Measurement Results and Reproducibility. Particuology 2010, 8, 279-285.
Knop, K.; Hoogenboom, R.; Fischer, D.; Schubert, U. S. Poly(Ethylene Glycol) in Drug Delivery: Pros and Cons as Well as Potential Alternatives. Angew. Chem., Int. Ed. 2010, 49, 6288-6308.
Novo, L.; Takeda, K. M.; Petteta, T.; Dakwar, G. R.; van den Dikkenberg, J. B.; Remaut, K.; Braeckmans, K.; van Nostrum, C. F.; Mastrobattista, E.; Hennink, W. E. Targeted Decationized Polyplexes for siRNA Delivery. Mol. Pharmaceutics 2015, 12, 150-161.
Oliveira, A. C.; Raemdonck, K.; Martens, T.; Rombouts, K.; Simon-Vazquez, R.; Botelho, C.; Lopes, I.; Lucio, M.; Gonzalez-Fernandez, A.; Real Oliveira, M. E.; Gomes, A. C.; Braeckmans, K. Stealth Monoolein-Based Nanocarriers for Delivery of siRNA to Cancer Cells. Acta Biomater. 2015, 25, 216-229.
Rother, R. P.; Bell, L.; Hillmen, P.; Gladwin, M. T. The Clinical Sequelae of Intravascular Hemolysis and Extracellular Plasma Hemoglobin: A Novel Mechanism of Human Disease. Jama 2005, 293, 1653-1662.
Wang, T.; Upponi, J. R.; Torchilin, V. P. Design of Multifunctional Non-Viral Gene Vectors to Overcome Physiological Barriers: Dilemmas and Strategies. Int. J. Pharm. 2012, 427, 3-20.
Mishra, S.; Webster, P.; Davis, M. E. PEGylation Significantly Affects Cellular Uptake and Intracellular Trafficking of Non-Viral Gene Delivery Particles. Eur. J. Cell Biol. 2004, 83, 97-111.
Hama, S.; Itakura, S.; Nakai, M.; Nakayama, K.; Morimoto, S.; Suzuki, S.; Kogure, K. Overcoming the Polyethylene Glycol Dilemma Via Pathological Environment-Sensitive Change of the Surface Property of Nanoparticles for Cellular Entry. J. Controlled Release 2015, 206, 67-74.
Dakwar, G. R.; Braeckmans, K.; Demeester, J.; Ceelen, W.; Smedt, S. C. D.; Remaut, K. Disregarded Effect of Biological Fluids in siRNA Delivery: Human Ascites Fluid Severely Restricts Cellular Uptake of Nanoparticles. ACS Appl. Mater. Interfaces 2015, 7, 24322-24329.
Fleischer, C. C.; Payne, C. K. Nanoparticle-Cell Interactions: Molecular Structure of the Protein Corona and Cellular Outcomes. Acc. Chem. Res. 2014, 47, 2651-2659.
Hadjidemetriou, M.; Al-Ahmady, Z.; Mazza, M.; Collins, R. F.; Dawson, K.; Kostarelos, K. In Vivo Biomolecule Corona around Blood-Circulating, Clinically Used and Antibody-Targeted Lipid Bilayer Nanoscale Vesicles. ACS Nano 2015, 9, 8142-8156.
Weissig, V.; Pettinger, T. K.; Murdock, N. Nanopharmaceuticals (Part 1): Products on the Market. Int. J. Nanomed. 2014, 9, 4357-4373.
Young, S. W.; Stenzel, M.; Jia-Lin, Y. Nanoparticle-siRNA: A Potential Cancer Therapy? Crit. Rev. Oncol. Hematol. 2016, 98, 159-169.
Mo, R.; Gu, Z. Tumor Microenvironment and Intracellular Signal-Activated Nanomaterials for Anticancer Drug Delivery. Mater. Today 2016, 19 (5), 274-283.
Hatakeyama, H.; Akita, H.; Kogure, K.; Oishi, M.; Nagasaki, Y.; Kihira, Y.; Ueno, M.; Kobayashi, H.; Kikuchi, H.; Harashima, H. Development of a Novel Systemic Gene Delivery System for Cancer Therapy with a Tumor-Specific Cleavable PEG-Lipid. Gene Ther. 2007, 14, 68-77.
Dufay Wojcicki, A.; Hillaireau, H.; Nascimento, T. L.; Arpicco, S.; Taverna, M.; Ribes, S.; Bourge, M.; Nicolas, V.; Bochot, A.; Vauthier, C.; Tsapis, N.; Fattal, E. Hyaluronic Acid-Bearing Lipoplexes: Physico-Chemical Characterization and in Vitro Targeting of the CD44 Receptor. J. Controlled Release 2012, 162, 545-552.
